Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome
| Autor: | Olaniyi, Kehinde S., Areloegbe, Stephanie E., Areola, Emmanuel D., Sabinari, Isaiah W., Fafure, Adedamola A., Agbana, Richard D., Atuma, Chukwubueze L., Shah, Mohd Zahoor ul haq, Ajadi, Isaac O., Olatunji, Lawrence A. |
|---|---|
| Zdroj: | In Toxicology and Applied Pharmacology 15 August 2023 473 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect